10-15 Associates’s Elevance Health ELV Stock Holding History

10-15 Associates’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$13.2M	Buy	49,094 +207	+0.4%	+$55.7K	2.56%	15
2020 Q2	$12.9M	Buy	48,887 +4,627	+10%	+$1.23M	2.59%	16
2020 Q1	$10M	Sell	44,260 -447	-1%	-$122K	2.34%	20
2019 Q4	$13.5M	Sell	44,707 -223	-0.5%	-$61.4K	2.55%	11
2019 Q3	$10.8M	Buy	44,930 +781	+2%	+$214K	2.22%	23
2019 Q2	$12.5M	Buy	44,149 +892	+2%	+$244K	2.7%	12
2019 Q1	$12.4M	Buy	43,257 +480	+1%	+$139K	2.67%	14
2018 Q4	$11.2M	Buy	42,777 +1,306	+3%	+$359K	2.75%	15
2018 Q3	$11.4M	Buy	+41,471	New	+$10.8M	2.55%	15

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

10-15 Associates's ELV Position: Q3 2020 in Review

10-15 Associates increased its Elevance Health (ELV) stake by 0.42% in Q3 2020, buying an estimated $55.7K and bringing the position to 49,094 shares worth $13.2M. The position accounts for 2.56% of the portfolio, ranked #15.

10-15 Associates first reported a position in ELV in Q3 2018 and has held it in 9 quarters since. The position peaked at $13.5M in Q4 2019. 1,094 funds tracked by Wall St. Rank hold ELV as of Q3 2020.

10-15 Associates held 49,094 shares of Elevance Health worth $13.2M as of Q3 2020.
10-15 Associates bought 207 Elevance Health shares in Q3 2020, an estimated $55.7K.
Elevance Health made up 2.56% of 10-15 Associates's portfolio in Q3 2020, its #15 holding.
10-15 Associates first reported a position in Elevance Health in Q3 2018 and has held it in 9 quarters since.
10-15 Associates's Elevance Health position peaked at $13.5M in Q4 2019.
1,094 funds tracked by Wall St. Rank held Elevance Health as of Q3 2020.

Based on 10-15 Associates's 13F filing for Q3 2020, filed 13 Oct 2020.